Literature DB >> 25016083

Image-guided interventional therapy for cancer with radiotherapeutic nanoparticles.

William T Phillips1, Ande Bao2, Andrew J Brenner3, Beth A Goins4.   

Abstract

One of the major limitations of current cancer therapy is the inability to deliver tumoricidal agents throughout the entire tumor mass using traditional intravenous administration. Nanoparticles carrying beta-emitting therapeutic radionuclides that are delivered using advanced image-guidance have significant potential to improve solid tumor therapy. The use of image-guidance in combination with nanoparticle carriers can improve the delivery of localized radiation to tumors. Nanoparticles labeled with certain beta-emitting radionuclides are intrinsically theranostic agents that can provide information regarding distribution and regional dosimetry within the tumor and the body. Image-guided thermal therapy results in increased uptake of intravenous nanoparticles within tumors, improving therapy. In addition, nanoparticles are ideal carriers for direct intratumoral infusion of beta-emitting radionuclides by convection enhanced delivery, permitting the delivery of localized therapeutic radiation without the requirement of the radionuclide exiting from the nanoparticle. With this approach, very high doses of radiation can be delivered to solid tumors while sparing normal organs. Recent technological developments in image-guidance, convection enhanced delivery and newly developed nanoparticles carrying beta-emitting radionuclides will be reviewed. Examples will be shown describing how this new approach has promise for the treatment of brain, head and neck, and other types of solid tumors. Published by Elsevier B.V.

Entities:  

Keywords:  Beta-emitting radionuclides; Convection enhanced delivery; Drug delivery; Imaging; Liposomes; Radionuclide therapy; Rhenium-186; Solid tumor

Mesh:

Substances:

Year:  2014        PMID: 25016083      PMCID: PMC4414016          DOI: 10.1016/j.addr.2014.07.001

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  207 in total

1.  Imaging, autoradiography, and biodistribution of (188)Re-labeled PEGylated nanoliposome in orthotopic glioma bearing rat model.

Authors:  Feng-Yun J Huang; Te-Wei Lee; Chih-Hao K Kao; Chih-Hsien Chang; Xiaoning Zhang; Wan-Yu Lee; Wan-Jou Chen; Shu-Chi Wang; Jem-Mau Lo
Journal:  Cancer Biother Radiopharm       Date:  2011-12       Impact factor: 3.099

2.  Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model.

Authors:  Ryuta Saito; Michal T Krauze; Charles O Noble; Daryl C Drummond; Dmitri B Kirpotin; Mitchel S Berger; John W Park; Krystof S Bankiewicz
Journal:  Neuro Oncol       Date:  2006-05-24       Impact factor: 12.300

Review 3.  Clinical trials with intracerebral convection-enhanced delivery of targeted toxins in malignant glioma.

Authors:  N G Rainov; K Gorbatyuk; V Heidecke
Journal:  Rev Recent Clin Trials       Date:  2008-01

4.  Hyperthermia increases accumulation of technetium-99m-labeled liposomes in feline sarcomas.

Authors:  M L Matteucci; G Anyarambhatla; G Rosner; C Azuma; P E Fisher; M W Dewhirst; D Needham; D E Thrall
Journal:  Clin Cancer Res       Date:  2000-09       Impact factor: 12.531

5.  Tumor eradication in rat glioma and bypass of immunosuppressive barriers using internal radiation with (188)Re-lipid nanocapsules.

Authors:  Claire Vanpouille-Box; Franck Lacoeuille; Camille Belloche; Nicolas Lepareur; Laurent Lemaire; Jean-Jacques LeJeune; Jean-Pierre Benoît; Philippe Menei; Olivier F Couturier; Emmanuel Garcion; François Hindré
Journal:  Biomaterials       Date:  2011-06-25       Impact factor: 12.479

6.  Poor drug distribution as a possible explanation for the results of the PRECISE trial.

Authors:  John H Sampson; Gary Archer; Christoph Pedain; Eva Wembacher-Schröder; Manfred Westphal; Sandeep Kunwar; Michael A Vogelbaum; April Coan; James E Herndon; Raghu Raghavan; Martin L Brady; David A Reardon; Allan H Friedman; Henry S Friedman; M Inmaculada Rodríguez-Ponce; Susan M Chang; Stephan Mittermeyer; David Croteau; Raj K Puri
Journal:  J Neurosurg       Date:  2010-08       Impact factor: 5.115

Review 7.  Nanoparticle-based theranostic agents.

Authors:  Jin Xie; Seulki Lee; Xiaoyuan Chen
Journal:  Adv Drug Deliv Rev       Date:  2010-08-04       Impact factor: 15.470

8.  Combination radiofrequency ablation and intravenous radiolabeled liposomal Doxorubicin: imaging and quantification of increased drug delivery to tumors.

Authors:  Hayden W Head; Gerald D Dodd; Ande Bao; Anuradha Soundararajan; Xavier Garcia-Rojas; Thomas J Prihoda; Linda M McManus; Beth A Goins; Cristina A Santoyo; William T Phillips
Journal:  Radiology       Date:  2010-05       Impact factor: 11.105

Review 9.  Anti-tumour strategies aiming to target tumour-associated macrophages.

Authors:  Xiaoqiang Tang; Chunfen Mo; Yongsheng Wang; Dandan Wei; Hengyi Xiao
Journal:  Immunology       Date:  2013-02       Impact factor: 7.397

10.  Nanovectorized radiotherapy: a new strategy to induce anti-tumor immunity.

Authors:  Claire Vanpouille-Box; François Hindré
Journal:  Front Oncol       Date:  2012-10-10       Impact factor: 6.244

View more
  22 in total

1.  Theranostic Multilayer Capsules for Ultrasound Imaging and Guided Drug Delivery.

Authors:  Jun Chen; Sithira Ratnayaka; Aaron Alford; Veronika Kozlovskaya; Fei Liu; Bing Xue; Kenneth Hoyt; Eugenia Kharlampieva
Journal:  ACS Nano       Date:  2017-03-10       Impact factor: 15.881

Review 2.  Advancement in treatment and diagnosis of pancreatic cancer with radiopharmaceuticals.

Authors:  Yu-Ping Xu; Min Yang
Journal:  World J Gastrointest Oncol       Date:  2016-02-15

Review 3.  Strategies for improving the intratumoral distribution of liposomal drugs in cancer therapy.

Authors:  Beth Goins; William T Phillips; Ande Bao
Journal:  Expert Opin Drug Deliv       Date:  2016-04-04       Impact factor: 6.648

Review 4.  Integrating mechanism-based modeling with biomedical imaging to build practical digital twins for clinical oncology.

Authors:  Chengyue Wu; Guillermo Lorenzo; David A Hormuth; Ernesto A B F Lima; Kalina P Slavkova; Julie C DiCarlo; John Virostko; Caleb M Phillips; Debra Patt; Caroline Chung; Thomas E Yankeelov
Journal:  Biophys Rev (Melville)       Date:  2022-05-17

5.  PEG2000-DBCO surface coating increases intracellular uptake of liposomes by breast cancer xenografts.

Authors:  Daxing Liu; Jules Cohen; Nashaat Turkman
Journal:  Sci Rep       Date:  2022-06-22       Impact factor: 4.996

6.  Evaluation of 188Re-labeled PEGylated nanoliposome as a radionuclide therapeutic agent in an orthotopic glioma-bearing rat model.

Authors:  Feng-Yun J Huang; Te-Wei Lee; Chih-Hsien Chang; Liang-Cheng Chen; Wei-Hsin Hsu; Chien-Wen Chang; Jem-Mau Lo
Journal:  Int J Nanomedicine       Date:  2015-01-09

Review 7.  Synthetic nanoparticles for delivery of radioisotopes and radiosensitizers in cancer therapy.

Authors:  Jun Zhao; Min Zhou; Chun Li
Journal:  Cancer Nanotechnol       Date:  2016-11-16

8.  Near-Infrared Light Triggered ROS-activated Theranostic Platform based on Ce6-CPT-UCNPs for Simultaneous Fluorescence Imaging and Chemo-Photodynamic Combined Therapy.

Authors:  Caixia Yue; Chunlei Zhang; Gabriel Alfranca; Yao Yang; Xinquan Jiang; Yuming Yang; Fei Pan; Jesús M de la Fuente; Daxiang Cui
Journal:  Theranostics       Date:  2016-02-05       Impact factor: 11.556

Review 9.  Stimuli-Responsive Gold Nanoparticles for Cancer Diagnosis and Therapy.

Authors:  Li Tian; Linfeng Lu; Yang Qiao; Saisree Ravi; Ferandre Salatan; Marites P Melancon
Journal:  J Funct Biomater       Date:  2016-07-21

Review 10.  Interventional Nanotheranostics of Pancreatic Ductal Adenocarcinoma.

Authors:  Junjie Li; Fengyong Liu; Sanjay Gupta; Chun Li
Journal:  Theranostics       Date:  2016-06-15       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.